This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are You Looking for a High-Growth Dividend Stock? Eastman Chemical (EMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
EMN vs. APD: Which Stock Is the Better Value Option?
by Zacks Equity Research
EMN vs. APD: Which Stock Is the Better Value Option?
4 Diversified Chemical Stocks Set to Ride the Industry's Upswing
by Anindya Barman
An upturn in demand in major end-markets from the pandemic-induced slump should enable the Zacks Chemicals Diversified industry to thrive. DOW, PPG, OLN and CBT are set to gain from the improving industry fundamentals and strategic actions.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
An uptick in end-market demand and benefits of self-help actions are likely to reflect on the performance of DuPont (DD), Westlake (WLK), Koppers (KOP) and Trinseo (TSE) in Q1.
Eastman Chemical (EMN) Earnings & Sales Top Estimates in Q1
by Zacks Equity Research
Eastman Chemical (EMN) benefits from innovation-driven growth model, operational execution and cost-management actions in Q1.
Eastman Chemical (EMN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 4.93% and 3.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Eastman Chemical's (EMN) Q1 performance is likely to have benefited from cost-management actions and recovery across building & construction, automotive and consumer durables markets.
Analysts Estimate Eastman Chemical (EMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This is Why Eastman Chemical (EMN) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
PPG Industries (PPG) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of restructuring actions, acquisitions and improved demand are likely to get reflected on PPG Industries' (PPG) Q1 results.
Why Eastman Chemical (EMN) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman (EMN) to Expand Extrusion Capabilities at Springfield
by Zacks Equity Research
The investment bolsters Eastman Chemical's (EMN) supply capabilities to address regional and global demand for Saflex PVB products in automotive and architectural markets.
Eastman Chemical (EMN) Stock Rallies 38% in 6 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) benefits from its innovation-driven growth model, cost-management actions and improved demand across its end markets.
Are You Looking for a High-Growth Dividend Stock? Eastman Chemical (EMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Huntsman (HUN) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Huntsman (HUN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Dow Inc. (DOW) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Dow Inc. (DOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Eastman Chemical (EMN) Stock Up 11% in 3 Months: Here's Why
by Zacks Equity Research
Forecast-topping earnings performance in Q4 and upbeat outlook for 2021 have contributed to the gain in Eastman Chemical's (EMN) shares.
EMN vs. AIQUY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EMN vs. AIQUY: Which Stock Is the Better Value Option?
US Chemical Production Continues to Leap: 5 Stocks to Buy Now
by Anindya Barman
The U.S. chemical industry has pulled off a comeback from coronavirus-induced challenges, aided by a return of economic activities. WLK, DOW, PPG, EMN and HUN are worth betting on right now.
Are You Looking for a High-Growth Dividend Stock? Eastman Chemical (EMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Up 9.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Eastman Chemical (EMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eastman Chemical (EMN) Is Up 2.46% in One Week: What You Should Know
by Zacks Equity Research
Does Eastman Chemical (EMN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Hawkins (HWKN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Dow Inc. (DOW) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dow Inc. (DOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical